Andrea Casey
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Andrea Casey has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Alice R. T. Bergin
Peter MacCallum Cancer Centre Melbourne Victoria Australia
4 shared publications - Andrew Redfern
Harry Perkins Institute of Medical Research, 5 Robin Warren Dr., Murdoch, WA 6150, Australia
4 shared publications - Benjamin F. Dessauvagie
PathWest Lab. Medicine WA (Australia)
4 shared publications - Franco Caramia
Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Australia
4 shared publications - Gail Garvey
The University of Queensland
4 shared publications - Jasmine Kay
Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
4 shared publications
Latest Publications
- Open Access
- 1 July 2025
- Published by American Association for Cancer Research (AACR)
Figure S1 from Aboriginal and Torres Strait Islander Females and Survival from Breast Cancer
Bar charts showing significantly more Aboriginal females live in areas of greatest socioeconomic disadvantage and outside the greater metropolitan area
- 1 July 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Aboriginal and Torres Strait Islander Females and Survival from Breast Cancer
Bar charts showing significantly more Aboriginal females live in areas of greatest socioeconomic disadvantage and outside the greater metropolitan area
- Open Access
- 1 July 2025
- Published by American Association for Cancer Research (AACR)
Table S2 from Aboriginal and Torres Strait Islander Females and Survival from Breast Cancer
Analysis of co-variates for Aboriginal females and females from TCGA
- 1 July 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S2 from Aboriginal and Torres Strait Islander Females and Survival from Breast Cancer
Analysis of co-variates for Aboriginal females and females from TCGA
- Open Access
- 1 July 2025
- Published by American Association for Cancer Research (AACR)
Table S1 from Aboriginal and Torres Strait Islander Females and Survival from Breast Cancer
Immune-biology data for Aboriginal females and females from TCGA with breast cancer
- 1 July 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S1 from Aboriginal and Torres Strait Islander Females and Survival from Breast Cancer
Immune-biology data for Aboriginal females and females from TCGA with breast cancer
- 29 April 2025
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 34 (7) , 1167-1176
Aboriginal and Torres Strait Islander Females and Survival from Breast Cancer
Background: Despite access to universal health care, Aboriginal and Torres Strait Islander females (hereafter respectfully referred to as Aboriginal) in Australia have higher breast cancer incidence and mortality rates. We investigated the factors contributing to these survival disparities. Methods: Aboriginal females (n = 395; 0.7%) and non-Aboriginal females (n = 57,618; 99.3%) with breast cancer were identified from Victoria, Australia. Clinical, pathologic, demographic, and socioeconomic variables were analyzed. Endpoints were all-cause and breast cancer–specific mortality. HRs were estimated using Cox regression. Stromal tumor–infiltrating lymphocytes were evaluated from a subset of Aboriginal females and compared with females in The Cancer Genome Atlas. Results: Registry data revealed that Aboriginal females were younger (P < 0.001), had more advanced stage disease (P = 0.007), and were more likely to live in nonmetropolitan areas (P < 0.001) and in areas of greater disadvantage (P < 0.001) compared with other females at diagnosis. Age-adjusted multivariate analysis revealed a higher all-cause mortality risk (HR 1.27; 95% confidence interval, 1–1.61) for Aboriginal females, but this risk diminished for breast cancer–specific mortality and after adjustment for stage and grade. Breast cancers from Aboriginal females had significantly reduced stromal tumor–infiltrating lymphocytes in the luminal and triple-negative subtypes compared with The Cancer Genome Atlas. Conclusions: Mortality for females with breast cancer was influenced by socioeconomic, geographic, and clinical factors. Notably, Aboriginal females with tumor features typically associated with favorable outcomes experienced poorer outcomes. The reduced immune infiltrate warrants further investigation. Impact: These findings highlight the need to address socioeconomic inequities and ensure culturally safe cancer care. Further research should explore biological and environmental factors influencing outcomes for Australian Aboriginal females.
- 29 April 2025
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 34 (7) , 1167-1176
Aboriginal and Torres Strait Islander Females and Survival from Breast Cancer
Background: Despite access to universal health care, Aboriginal and Torres Strait Islander females (hereafter respectfully referred to as Aboriginal) in Australia have higher breast cancer incidence and mortality rates. We investigated the factors contributing to these survival disparities. Methods: Aboriginal females (n = 395; 0.7%) and non-Aboriginal females (n = 57,618; 99.3%) with breast cancer were identified from Victoria, Australia. Clinical, pathologic, demographic, and socioeconomic variables were analyzed. Endpoints were all-cause and breast cancer–specific mortality. HRs were estimated using Cox regression. Stromal tumor–infiltrating lymphocytes were evaluated from a subset of Aboriginal females and compared with females in The Cancer Genome Atlas. Results: Registry data revealed that Aboriginal females were younger (P < 0.001), had more advanced stage disease (P = 0.007), and were more likely to live in nonmetropolitan areas (P < 0.001) and in areas of greater disadvantage (P < 0.001) compared with other females at diagnosis. Age-adjusted multivariate analysis revealed a higher all-cause mortality risk (HR 1.27; 95% confidence interval, 1–1.61) for Aboriginal females, but this risk diminished for breast cancer–specific mortality and after adjustment for stage and grade. Breast cancers from Aboriginal females had significantly reduced stromal tumor–infiltrating lymphocytes in the luminal and triple-negative subtypes compared with The Cancer Genome Atlas. Conclusions: Mortality for females with breast cancer was influenced by socioeconomic, geographic, and clinical factors. Notably, Aboriginal females with tumor features typically associated with favorable outcomes experienced poorer outcomes. The reduced immune infiltrate warrants further investigation. Impact: These findings highlight the need to address socioeconomic inequities and ensure culturally safe cancer care. Further research should explore biological and environmental factors influencing outcomes for Australian Aboriginal females.